product summary
company name :
MilliporeSigma
other brands :
FLUKA, Sigma-Aldrich, Roche Applied Science
product type :
antibody
product name :
Monoclonal Anti-Alkaline Phosphatase, Human Placental-Agarose antibody produced in mouse
catalog :
A2080
clonality :
monoclonal
host :
mouse
conjugate :
agarose
clone name :
8B6
reactivity :
hamsters, human
application :
immunoprecipitation
more info or order :
citations: 2
Published Application/Species/Sample/Dilution | Reference |
---|---|
| |
product information
cat no :
A2080
brand :
SIGMA
name :
Monoclonal Anti-Alkaline Phosphatase, Human Placental-Agarose antibody produced in mouse
prod type :
Chemical
name suffix :
clone 8B6, purified immunoglobulin, PBS suspension
storage :
2-8C
storage temp :
2-8C
physical form :
Suspension in 0.1 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.
shipped in :
wet ice
syns :
Monoclonal Anti-Alkaline Phosphatase, Human Placental; Anti-Phosphatase, Alkaline, Human Placental; PLAP
mdl no :
MFCD00162106
unspsc code :
12352203
wgk :
3
form :
PBS suspension
antibody form :
purified immunoglobulin
application(s) :
immunoprecipitation: suitable
species reactivity :
human
immunogen :
Human epidermoid carcinoma cell line expressing placental alkaline phosphatase.
clone :
8B6
application :
Anti-Alkaline phosphatase human placental antibody coupled to agarose was packed in a column and used to purify alkaline-phosphatase conjugated FGF receptor out of conditioned media from COS-7 cells. Column was washed with 1M NaCl.1; Cultured pancreatic islet cells were fixed with cold 4% paraformaldhyde at room temperature for 10 minutes and incubated with mouse monoclonal anti-Alkaline Phosphatase, Human Placental antibody at 1:500. Mouse monoclonal anti-Alkaline Phosphatase, Human Placental antibody was used to detect a unique molecular probe that consisted of the FGFR extracellular domain expressed as a chimera with human PLAP.
more info or order :
company information

MilliporeSigma
related products
browse more products
questions and comments